Intraocular tumors are evaluated with a variety of diagnostic imaging technologies to make a diagnosis and create a personalized clinical plan. Benign lesions such as choroidal nevi, hemangiomas, and osteomas are typically monitored but may be treated to improve vision. Malignancies such as uveal melanoma, or metastasis of cancer to the eye, are treated in coordination with oncology teams. Procedures offered may include vitrectomy, biopsy, laser-based therapies, plaque brachytherapy (radiation treatment), or in rare cases enucleation (removal of the eye).
Leading our ocular oncology department is Dr. Peter Hovland, a renowned ophthalmologist, surgeon and founding partner at Colorado Retina Associates. Dr. Hovland and his team of trained specialists focus on the surgical and medical treatment of all types of intraocular tumors, from the most common to complex. Dr. Hovland has cared for thousands of patients from around the US with benign and malignant eye tumors, including ocular melanoma, choroidal or iris nevus, choroidal metastases and other vision threatening retinal conditions. Dr. Hovland is also actively involved in supporting the fight to find a cure for cure ocular melanoma, and currently acts as a grant reviewer for the Melanoma Research Foundation and the Ocular Melanoma Foundation.
Amanda Sisco works in collaboration with Dr. Peter Hovland as Colorado Retina’s Supervisor of Oncology Services. Amanda has been with Colorado Retina for the past five years and works closely with our oncology patients to ensure they are well informed and cared for through the phases of testing, diagnosis, treatment and follow-up. Amanda was awarded the 2019 CURE OM Vision of Hope Award at the Melanoma Research Foundation’s 8th Annual Denver Gala for her advocacy work surrounding ocular melanoma patient support, treatment and care. Amanda is also co-chair of the Melanoma Research Foundation’s Treatment Center Collaborative Coalition.